The trials are not being unblinded on Monday as discussed many times on this board, NP misspoke on the wall street reporter call and clarified himself on a subsequent proactive video call.
In addition, a company can discuss results prior to full FDA submission to the fda like cydy did on the HIV combo study well in advance of formal submission.
Let’s all see what is discussed in the call tomorrow and comment on It afterward - I for one am looking forward to listening in.

IMO